PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1643646
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1643646
The global intraoperative neuromonitoring (IONM) market is projected to grow from USD 3,658.4 million in 2024 to USD 5,635.1 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.7% during 2025-2032. This growth is fueled by the rising prevalence of chronic diseases, advancements in surgical techniques, and increasing demand for patient safety during complex procedures.
Key Insights
The growing incidence of lifestyle-related chronic diseases, such as cardiovascular and neurological conditions, is driving the demand for IONM to enhance patient safety during surgeries.
The aging global population, which is more susceptible to chronic diseases requiring surgical interventions, is contributing to the market's growth.
The preference for minimally invasive surgeries is increasing, necessitating advanced neuromonitoring techniques to ensure patient safety and improve surgical outcomes.
Technological advancements in neuromonitoring systems are enhancing their accuracy and reliability, leading to broader adoption in various surgical procedures.
North America holds the largest market share, driven by advanced healthcare infrastructure and high adoption of innovative medical technologies. The Asia-Pacific region is expected to experience the fastest growth due to increasing healthcare investments, rising awareness of patient safety, and a growing number of surgical procedures.